| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,854 |
3,060 |
$931K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,481 |
1,803 |
$678K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,012 |
1,410 |
$560K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
649 |
442 |
$437K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,089 |
902 |
$136K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
572 |
486 |
$121K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,189 |
1,045 |
$85K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
423 |
363 |
$40K |
| 80053 |
Comprehensive metabolic panel |
4,353 |
3,278 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,324 |
3,922 |
$27K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
935 |
784 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,277 |
1,049 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,056 |
1,554 |
$14K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
33 |
27 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
538 |
451 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
491 |
431 |
$9K |
| 87631 |
|
97 |
88 |
$8K |
| 81001 |
|
3,085 |
2,455 |
$7K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
16 |
13 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
237 |
213 |
$6K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
15 |
13 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
16 |
12 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
116 |
75 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
6,797 |
4,656 |
$4K |
| 84484 |
|
617 |
400 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
305 |
229 |
$3K |
| 80305 |
|
187 |
156 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
453 |
343 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
143 |
124 |
$2K |
| 83735 |
|
648 |
458 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
374 |
266 |
$2K |
| 85610 |
|
735 |
487 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
886 |
594 |
$974.33 |
| 83690 |
|
203 |
157 |
$852.31 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
12 |
$818.03 |
| 87088 |
|
199 |
144 |
$791.40 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
44 |
12 |
$688.52 |
| 83605 |
|
85 |
57 |
$572.40 |
| 83880 |
|
50 |
40 |
$567.98 |
| 81025 |
|
43 |
38 |
$424.28 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
43 |
38 |
$311.55 |
| 86140 |
|
64 |
40 |
$144.45 |
| 82150 |
|
30 |
28 |
$127.30 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
473 |
304 |
$20.53 |
| 36416 |
|
34 |
25 |
$10.98 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
852 |
532 |
$10.02 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
883 |
606 |
$8.83 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20 |
18 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
101 |
58 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
114 |
77 |
$0.00 |